Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Not a single study

Story checked

Kansas researchers secure NIH funding to fight antibiotic resistance (opens in a new tab)

news-medical.net · 2026-09-25

Short answerEvidenceSource

Short answer

Not a single study

No clear answer.

The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

This story isn't reporting one study.

The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.

Open claim evidence
3

Search result

No single source study.

The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.

Related research

Research nearby

Research on this topic

Nearby papers when the source is unclear.

and 11 more considered

Then inspect each claim

Evidence layer

Claim by claim

What the story asserts. With no source study, there is nothing to check these against.

Claim 1 of 5Not checkedThe NIH recently awarded the University of Kansas $5.8 million for Phase 3 of KU's Chemical Biology of Infectious Disease center, a COBRE established in 2016.View evidenceHide evidence

As stated$5.8 million

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 2 of 5Not checkedThe center recruits, mentors and supports investigators across KU, KU Medical Center, Kansas State, Wichita State and other regional partners as they address infectious disease and antibiotic resistance using chemical-biology approaches.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 3 of 5Not checkedUnder Phase 3, the research theme will be fighting antibiotic resistance by pursuing more targeted treatments rather than broad-spectrum antibiotics, with the goal of protecting the body's beneficial microbiome while defeating resistance mechanisms.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 4 of 5Not checkedHefty said the center can point to seven faculty recruited, contributions to 15 startups, about $25 million in NIH funding over 10 years, $90 million from broader research projects, pilot projects and cores, more than 600 publications, and 80 scientific affiliates under Phase 1 and 2 funding.View evidenceHide evidence

As statedseven faculty recruited; 15 startups; about $25 million NIH funding; $90 million broader research funding; more than 600 publications; 80 scientific affiliates

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 5 of 5Not checkedThe article says the center's collaborative model is intended to support faculty development, retention, student and postdoctoral training, and regional workforce development.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Finally, the search trail

Method layer

No single source study was found.

NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.

Nearby research

No exact source, but these papers are close.

PubMed, Crossref, Europe PMC · 15 candidate papers

And 10 more candidates considered.